Asset Manager

Updated:

Tidal Vision Products

Tidal Vision Products was founded in 2015 by Craig Kasberg, a commercial fisherman who spent years discarding millions of pounds of crab shells before...

Tidal Vision Products

Tidal Vision Products was founded in 2015 by Craig Kasberg, a commercial fisherman who spent years discarding millions of pounds of crab shells before engineering a way to convert them into chitosan, a biopolymer with industrial applications in water treatment, textile manufacturing, and agriculture. The company emerged from Bellingham, Washington, with a thesis that shellfish waste could replace petrochemical-based chemistries at scale. The firm operates as an industrial biotechnology manufacturer, deploying proprietary extraction technology to produce chitosan at price points that compete directly with synthetic polymers. Its deployment covers three verticals: Tidal Clear for stormwater and industrial wastewater treatment, Tidal Tex for antimicrobial textile finishes, and Tidal Grow for crop yield enhancement. Publicly disclosed customers include municipal water districts, mining operations, and textile mills. The geographic footprint spans North America, with production facilities on the West Coast and distribution agreements extending into Southeast Asia and Europe. Kasberg has scaled the company through multiple venture rounds, attracting both impact investors and strategic industrials. In 2022, the firm closed a $16 million Series B led by Milliken & Company, signaling that a major synthetic polymer producer saw defensible demand for bio-based alternatives. Tidal Vision operates an adjacent structure in Cascade Bioproducts, its manufacturing arm, which handles raw material processing from fisheries across the Pacific Northwest and Alaska. The structural differentiator is sourcing: Tidal Vision is the only commercial-scale chitosan producer backward-integrated into fishery supply chains. It does not buy chitosan on the spot market and reprocess it; it owns the extraction chemistry from catch to finished product, giving it a cost structure no chemical distributor can replicate without owning a fleet relationship.

General information

Firm type

Chitosan biopolymer solutions

Year founded

2015

Location

Region

North America

Country

United States

City

Bellingham

Corporate office

Bellingham, WA, United States

Principals

Craig Kasberg

Founder & CEO

Sector focus

Industrial TechMaterials ScienceWaste & Recycling

Frequently asked questions

What problem does Tidal Vision solve that existing chemical companies could not?

Chitosan has been available as a flocculant for decades but was never adopted at scale because suppliers sold it as an expensive specialty chemical derived from inconsistent foreign shrimp shell supply chains. Tidal Vision vertically integrated into North Pacific crab fisheries — a waste stream Kasberg personally managed as a boat captain — and developed a proprietary continuous-flow extraction method that drops the production cost below petrochemical alternatives. This shifted chitosan from a niche lab chemical to an industrial commodity.

Is Tidal Vision still a venture-backed startup or does it operate as a commercial-stage company?

The 2022 Series B and the presence of a strategic corporate lead investor indicate the company has moved beyond proof-of-concept. It services paying municipal and industrial contracts across three distinct verticals — water, textiles, agriculture — which is revenue structure more typical of a growth-stage industrial company than a pre-revenue biotech startup. It has not disclosed reaching profitability.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Explore more profiles